<DOC>
	<DOCNO>NCT00540124</DOCNO>
	<brief_summary>The primary purpose clinical trial evaluate change International Prostate Symptom Score ( IPSS ) total score beginning study end study subject randomize tadalafil 5mg day dose placebo day dose 12 week treatment .</brief_summary>
	<brief_title>Pilot Study Investigating Safety Efficacy Tadalafil Treatment Benign Prostatic Hyperplasia ( BPH ) Asian Men</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Have Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms ( BPHLUTS ) least 6 month prior Visit 1 . Agree use approve experimental treatment erectile dysfunction BPHLUTS study . Have take Finasteride therapy least 3 month prior Visit 2 . Have take Dutasteride therapy least 6 month prior Visit 2 . Have International Prostate Symptom Score ( IPSS ) total score great equal 13 Visit 2 . Prostate Specific Antigen ( PSA ) great 10.0 nanogram per milliliter ( ng/mL ) Visit 1 . Bladder Post Void Residual ( PVR ) great equal 300 mL ultrasound Visit 1 . History pelvic surgery , prostatectomy , radiotherapy , penile implant surgery , low urinary tract malignancy trauma . Urinary tract infection inflammation current antibiotic therapy urinary tract infection Visit 1 . Glycosylated hemoglobin ( HbA1c ) great 9 % Visit 1 .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>